Sunniva Inc. (CSE: SNN) (OTCQX: SNNVF) Secures Cal
Post# of 66
- Sunniva’s Sun-Oil Facility in California will provide Farmacy Phactory with distilled oil products
- Extraction deal is a significant milestone for the company, cements its position as a reliable manufacturer of clean extracted products
- New clinic opened in Windsor, Ontario, via wholly owned subsidiary Natural Health Services
Sunniva Inc. (CSE: SNN) (OTCQX: SNNVF), a vertically integrated medical cannabis provider, has struck an extraction deal with Farmacy Phactory, a family-run California cannabis farm (http://nnw.fm/HCEf8). Through wholly owned subsidiary CP Logistics, LLC, Sunniva’s Sun-Oil Facility will provide high quality, pure manufactured distilled oil products, including flavored oil formulations for vaporization cartridges. Sunniva will also sell specialized vaporization equipment for use in the therapeutic delivery of the products.
The contract was signed for an initial 12-month term and may be renewed for a further 12 months if Farmacy Phactory elects to do so. Farmacy Phactory is a leading producer of unique high-terpene strains of cannabis, and it is making a name for itself with high-quality products. It combines organic methods with proven traditional techniques to produce a range of exotic strains (http://nnw.fm/VdXd9).
“This is a significant milestone as it establishes Sunniva as a trusted manufacturer of clean, high quality extracted products and reliable hardware to support the vibrant California extraction market place,” Sunniva CEO Dr. Anthony Holler stated in a news release. He explained that the Sun-Oil Facility, which is located one mile from the company’s California Campus in Cathedral City, has a capacity to produce more than 600,000 filled vaporization cartridges a month. The facility is licensed for both volatile and non-volatile extraction, which will allow Sunniva to manufacture different extracted products. The company also has plans to sign more white label contracts with other leading brands in the Golden State, Holler further explained.
“We are pleased to partner with Sunniva to access their manufacturing and product expertise. This agreement is a validation of their large-scale extraction operations and we are excited to bring new products to the California marketplace,” added Mark Greene, president of Farmacy Phactory.
Meanwhile, in Canada, Sunniva’s wholly owned subsidiary, Natural Health Services Ltd., the country’s largest referral network of clinics and trained health professionals, invited members of the public and the press for an open house at its Windsor, Ontario, clinic (http://nnw.fm/09I1u).
At the clinic’s grand opening celebration on May 30, regional manager Lisa Hogan said that this was the culmination of a long journey and that NHS was excited to be able to provide an important service for the local community (http://nnw.fm/HrYy2).
Speaking to Chris Foord, the host of the Cannabis Show (http://nnw.fm/0ZXDm), Hogan said, “We’re going to be focusing on an education-based model of care for our patients that focuses on safe access to medical cannabis: proper education, providing them with the insights of if it’s even a proper product for them, how it can help them, and then, of course, product matching and LP matching and connecting them to those services that will meet their needs.”
The clinic, which is free for patients at the point of use, is now open to take bookings.
With some experts estimating that up to 90 percent of California’s cannabis extracts may be tainted with pesticides, Sunniva’s main goal is to provide safe, cost-effective products. The company operates in the largest cannabis markets in the world – California and Canada, and it aims to become the lowest cost, highest quality cannabis manufacturer in these two markets by providing products that are free of pesticides and building large-scale greenhouses that are compliant with current Good Manufacturing Practices. Through this commitment to detail, Sunniva aims to enable better doctor and patient access to cannabis education and facilitate improved delivery devices for therapeutic purposes.
For more information, visit the company’s website at www.sunniva.com
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer